Abstract
Targeting cancer metabolism has emerged as an attractive approach to
improve therapeutic regimens in acute myeloid leukemia (AML).
Mitochondrial proteases are closely related to cancer metabolism, but
their biological functions have not been well characterized in AML.
According to different catogory, we comprehensively reviewed the role of
mitochondrial proteases in AML. This review highlights some ‘powerful’
mitochondrial protease targets, including their biological function,
chemical modulators, and applicative prospect in AML.